Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
aTyr Pharma, Inc. (ATYR) had Return on Investments of -90.53% for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$0.23M |
|
$-64.02M |
|
-- |
|
$0.23M |
|
$68.15M |
|
$-67.91M |
|
$3.89M |
|
$-64.02M |
|
$-64.02M |
|
$-64.02M |
|
$-64.02M |
|
$-64.02M |
|
$-64.02M |
|
$-67.91M |
|
$-69.08M |
|
74.26M |
|
74.26M |
|
$-0.86 |
|
$-0.86 |
|
| Balance Sheet Financials | |
$81.95M |
|
$4.85M |
|
$14.88M |
|
$96.83M |
|
$14.97M |
|
$0.89M |
|
$12.03M |
|
$27.00M |
|
$69.83M |
|
$69.83M |
|
$69.83M |
|
84.04M |
|
| Cash Flow Statement Financials | |
$-69.12M |
|
$17.23M |
|
$39.86M |
|
$26.03M |
|
$14.01M |
|
$-12.02M |
|
$2.99M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.48 |
|
-- |
|
-- |
|
0.01 |
|
0.02 |
|
100.00% |
|
-28899.58% |
|
-28899.58% |
|
-29395.32% |
|
-27243.40% |
|
-27243.83% |
|
$-69.18M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
0.14 |
|
2696.34 |
|
-91.68% |
|
-91.68% |
|
-66.12% |
|
|
Return on Investments |
-90.53% |
$0.83 |
|
$-0.93 |
|
$-0.93 |
|